Skip to main content

FDA recall, , Moderate risk

MedicaLyte and Citric Complete Concentrates

Hemodialysis concentrates contain high endotoxin levels.

What happened

Nipro Renal Soultions USA, Corporation of Lewisberry, Pennsylvania, recalled hemodialysis concentrates because they contain high endotoxin levels. The products include Citric Complete Dry Citric Acid Concentrate, MedicaLyte Liquid Bicarbonate Concentrate, MedicaLyte Bicarbonate Powder, and Citric Complete Liquid Citric Acid Concentrate.

The recall began August 5, 2026, and was added to the FDA's Enforcement Report on September 10, 2026. Distribution was in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

4 products

Affected if its lot code is listed.

  1. Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25

    Lot code
    • NDC5E015
  2. MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201

    Lot code
    • N4L022
    • N4L010
  3. MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))

    Lot code
    • NDB5E004
    • NDB5M011
  4. Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)

    Lot code
    • N4J030
    • N6A025

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution in the states of Florida, Georgia, Illinois, Maryland, Michigan, North Carolina, New Jersey, Nevada, Ohio, Pennsylvania, and the countries of Guatemala and Panama.

Company
Nipro Renal Soultions USA, CorporationLewisberry, Pennsylvania
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99573
Recall numbers
Z-3133-2026 to Z-3136-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)